Visceral leishmaniasis (kala-azar)—the Bihar (India) perspective

World Health Organization. Life in the twenty-first century: a vision for all. World health report. Geneva: World Health Organization; 1998. p. 45. 1993, Investing in health Desjeus, 1992, Human leishmaniasis: epidemiology and public health aspects, World Health Stat Q, 45, 267 Bora, 1999, Epidemiology of visceral leishmaniasis in India, Nat Med J, 12, 62 Sanyal, 1969, Some observations on epidemiology of the current outbreak of kala-azar in Bihar, J Infect Dis, 11, 170 Government of India. Economic attainment and well being. National human development report. Planning Commission, Government of India; 2001. p. 31–46. Bhattacharya, 2004, Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India, Clin Infect Dis, 38, 217, 10.1086/380638 Thakur, 1991, Comparison of regimen of treatment of antimony resistant kala-azar patients, Am J Trop Hyg, 45, 435, 10.4269/ajtmh.1991.45.435 Peter, 1981, The treatment of kala-azar: the new approaches to an old problem, Indian J Med Res, 73, 1 Sunder, 1997, Treatment of visceral leishmaniasis—current status, J Assoc Physicians India, 45, 640 Berman, 1998, Chemotherapy of leishmaniasis biochemical mechanism, clinical efficacy and future strategies, Rev Infect, 10, 560, 10.1093/clinids/10.3.560 Thakur, 2004, A comparative evaluation of amphotericin B and sodium antimony gluconate, as first-line drugs in the treatment of Indian visceral leishmaniasis, Ann Trop Med Parasitol, 98, 129, 10.1179/000349804225003154